KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Interest & Investment Income: 2013-2016

Historic Interest & Investment Income for TherapeuticsMD (TXMD) over the last 4 years, with Dec 2016 value amounting to $10,824.

  • TherapeuticsMD's Interest & Investment Income rose 35.07% to $3,867 in Q2 2017 from the same period last year, while for Jun 2017 it was $42,236, marking a year-over-year increase of 2.69%. This contributed to the annual value of $10,824 for FY2016, which is 37.94% down from last year.
  • TherapeuticsMD's Interest & Investment Income amounted to $10,824 in FY2016, which was down 37.94% from $17,442 recorded in FY2015.
  • In the past 5 years, TherapeuticsMD's Interest & Investment Income registered a high of $37,309 during FY2014, and its lowest value of $10,824 during FY2016.
  • Over the past 3 years, TherapeuticsMD's median Interest & Investment Income value was $17,442 (recorded in 2015), while the average stood at $21,858.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 36.99% in 2014, then plummeted by 53.25% in 2015.
  • TherapeuticsMD's Interest & Investment Income (Yearly) stood at $27,234 in 2013, then soared by 36.99% to $37,309 in 2014, then tumbled by 53.25% to $17,442 in 2015, then slumped by 37.94% to $10,824 in 2016.